-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 NAlq6iun6eszUnSfKgmNSpULTdIWoYEx8LhNsbp0i6V7drHtCPiKa6vkMchj/83D
 1+wNiIDMe0pFRjIyrHIRWQ==

<SEC-DOCUMENT>0001125282-04-002611.txt : 20040604
<SEC-HEADER>0001125282-04-002611.hdr.sgml : 20040604
<ACCEPTANCE-DATETIME>20040604154832
ACCESSION NUMBER:		0001125282-04-002611
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20040602
FILED AS OF DATE:		20040604

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EYETECH PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001115285
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				134104684
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		500 SEVENTH AVE 18TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		2129979241

	MAIL ADDRESS:	
		STREET 1:		500 SEVENTH AVE 18TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JP MORGAN PARTNERS BHCA LP
		CENTRAL INDEX KEY:			0001106607
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50516
		FILM NUMBER:		04849886

	BUSINESS ADDRESS:	
		STREET 1:		J.P. MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		2128993400

	MAIL ADDRESS:	
		STREET 1:		J.P. MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHASE EQUITY ASSOCIATES LLC
		DATE OF NAME CHANGE:	20000214

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			J P MORGAN CHASE & CO
		CENTRAL INDEX KEY:			0000019617
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50516
		FILM NUMBER:		04849884

	BUSINESS ADDRESS:	
		STREET 1:		270 PARK AVE
		STREET 2:		39TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		2122706000

	MAIL ADDRESS:	
		STREET 1:		270 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHASE MANHATTAN CORP /DE/
		DATE OF NAME CHANGE:	19960402

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHEMICAL BANKING CORP
		DATE OF NAME CHANGE:	19920703

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHEMICAL NEW YORK CORP
		DATE OF NAME CHANGE:	19880508

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JPMP MASTER FUND MANAGER L P
		CENTRAL INDEX KEY:			0001243235
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50516
		FILM NUMBER:		04849885

	BUSINESS ADDRESS:	
		STREET 1:		JP MORGAN PARTNERS LLC
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		212 899-3400

	MAIL ADDRESS:	
		STREET 1:		C/O JPMORGAN PARTNERS LLC
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JPMP CAPITAL CORP
		CENTRAL INDEX KEY:			0001243236
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50516
		FILM NUMBER:		04849887

	BUSINESS ADDRESS:	
		STREET 1:		C/O J.P. MORGAN PARTNERS, LLC
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		212 899-3400

	MAIL ADDRESS:	
		STREET 1:		C/O JPMORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

	FORMER NAME:	
		FORMER CONFORMED NAME:	JPMP CAPITAL LLC
		DATE OF NAME CHANGE:	20030618
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>b332455_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2004-06-02</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001115285</issuerCik>
        <issuerName>EYETECH PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>EYET</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001106607</rptOwnerCik>
            <rptOwnerName>JP MORGAN PARTNERS BHCA LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>J.P. MORGAN PARTNERS</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001243235</rptOwnerCik>
            <rptOwnerName>JPMP MASTER FUND MANAGER L P</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>JP MORGAN PARTNERS LLC</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001243236</rptOwnerCik>
            <rptOwnerName>JPMP CAPITAL CORP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O J.P. MORGAN PARTNERS, LLC</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000019617</rptOwnerCik>
            <rptOwnerName>J P MORGAN CHASE &amp; CO</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>270 PARK AVE</rptOwnerStreet1>
            <rptOwnerStreet2>39TH FL</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2004-06-02</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>810223</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>38.50</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3240896</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Director Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.44</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2002-12-03</value>
            </exerciseDate>
            <expirationDate>
                <value>2012-12-03</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>60000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>60000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Director Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>34.34</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2014-05-12</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>20000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>20000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These options were granted to Damion Wicker and Srinivas Akkaraju, directors of the Issuer. Mr. Wicker is Managing Director
of JPMP Capital Corp., the general partner of JPMP Master Fund Manager, L.P. (&quot;MF Manager&quot;), the general partner of J.P.
Morgan Partners (BHCA), L.P. (&quot;JPM BHCA&quot;). Mr. Akkaraju is a Principal at J.P. Morgan Partners, LLC and a limited partner
of MF Manager. Mr. Wicker and Mr. Akkaraju are obligated to transfer any shares issued under the stock option to JPM BHCA.</footnote>
        <footnote id="F2">These options will become exercisable on June 12, 2004. They will vest in 48 monthly installments.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Damion E. Wicker</signatureName>
        <signatureDate>2004-06-04</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>b332455_ex99-1.htm
<DESCRIPTION>ADDITIONAL EXHIBITS
<TEXT>
<html>
<head><title>
Prepared and filed by St Ives Burrups
</title>
</head>
<body bgcolor="#FFFFFF">  <p align="right"><font size="2" face="serif"><b>  Exhibit
      99.1</b></font></p>
<table width="100%" border="1" align="center" cellpadding="4" cellspacing="0" bordercolor="#000000">
<tr valign="top" bgcolor="#FFFFFF">
<td align="center" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Name and Address of Reporting Person<sup>1</sup></font></b></font></div></td>
<td width="8%" align="left" valign="bottom"><div align="center"><font size="2" face="serif"><font face="serif" size="1"><b>Designated Reporter</b></font><font size="2" face="serif"><b><font face="serif" size="1"><sup>1</sup></font></b></font></font></div></td>
<td width="8%" align="center" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Statement for Month/Day/Year</font></b></font></div></td>
<td width="8%" align="center" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Deemed
          Execution Date,</font></b></font> <font size="2" face="serif"><b><font face="serif" size="1">if
      any</font></b></font><br>
    <font size="2" face="serif"><b><font face="serif" size="1">(Month/Day/Year)</font></b></font></div></td>
<td width="8%" align="center" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Issuer
          Name, Ticker</font></b></font> <font size="2" face="serif"><b><font face="serif" size="1">or
        Trading Symbol</font></b></font></div></td>
<td width="8%" align="left" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Title of </font></b></font><br>
      <font size="2" face="serif"><b><font face="serif" size="1">Security</font></b></font></div></td>
<td width="8%" align="center" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Amount of Securities Beneficially Owned<sup>1</sup></font></b></font></div></td>
<td width="8%" align="center" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Title of Derivative Securities and Title and Amounts of Securities Underlying Derivative Securities</font></b></font></div></td>
<td width="8%" align="center" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Ownership
          Form:</font></b></font> <font size="2" face="serif"><b><font face="serif" size="1">Direct
          (D) or</font></b></font><br>
        <font size="2" face="serif"><b><font face="serif" size="1">Indirect (I)</font></b></font></div></td>
<td width="8%" align="center" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Nature
          of Indirect</font></b></font><br>
          <font size="2" face="serif"><b><font face="serif" size="1">Beneficial Ownership<sup>1</sup></font></b></font></div></td>
<td width="8%" align="left" valign="bottom"><div align="center"><font size="2" face="serif"><b><font face="serif" size="1">Disclaims</font></b></font><br>
      <font size="2" face="serif"><b><font face="serif" size="1">Pecuniary Interest</font></b></font></div></td>
</tr>
<tr valign="top" >
<td align="left" valign="bottom"><font size="2" face="Times New Roman, Times, serif">JPMP Master Fund Manager, L.P.<br>c/o J.P. Morgan Partners, LLC <br>1221 Avenue of the Americas, 40<sup>th</sup> Floor<br>New York, NY 10020</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">J.P. Morgan Partners (BHCA), L.P.</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">June 2, 2004</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">N/A</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">Eyetech Pharmaceuticals, Inc.<br>(&#8220;EYET&#8221;)</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">Common Stock</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">3,240,896</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">See Table II</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">I</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">See Explanatory<br>Note 2 below</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">No</font></td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="left" valign="bottom"><font size="2" face="Times New Roman, Times, serif">JPMP Capital Corporation<br>c/o J.P. Morgan Partners, LLC<br>1221 Avenue of the Americas, 40<sup>th</sup> Floor<br>New York, NY 10020</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">J.P. Morgan Partners (BHCA), L.P.</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">June 2, 2004</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">N/A</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">Eyetech Pharmaceuticals, Inc.<br>(&#8220;EYET&#8221;)</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">Common Stock</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">3,240,896</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">See Table II</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">I</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">See Explanatory<br>Note 3 below</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">No</font></td>
</tr>
<tr valign="top" >
<td align="left" valign="bottom"><font size="2" face="Times New Roman, Times, serif">J.P. Morgan Chase &amp; Co.<br>270 Park Avenue <br>35<sup>th</sup> Floor<br>New York, NY 10017</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">J.P. Morgan Partners (BHCA), L.P.</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">June 2, 2004</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">N/A</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">Eyetech Pharmaceuticals, Inc.<br>(&#8220;EYET&#8221;)</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">Common Stock</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">3,240,896</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">See Table II</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">I</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">See Explanatory<br>Note 4 below</font></td>
<td align="center" valign="bottom"><font size="2" face="Times New Roman, Times, serif">No</font></td>
</tr>
</table>
<p align="left"><font face="serif" size="2">Explanatory Note:</font></p>
<p align="left"><font face="serif" size="2">1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Designated Reporter is executing
    this report on behalf of all Reporting Persons, each of whom has authorized
    it to do so; each of such Persons disclaims beneficial ownership of the Issuer&#8217;s
    securities to the extent it exceeds such Person&#8217;s pecuniary interest
    therein.</font></p>
<p align="left"><font face="serif" size="2">2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amounts shown represent the
    beneficial ownership of the Issuer's equity securities by JPM BHCA, a portion
    of which may be deemed attributable to the Reporting Person because the Reporting
    Person is the general partner of JPM BHCA. The actual pro rata portion of
    such beneficial ownership that may be deemed to be attributable to the Reporting
    Person is not readily determinable because it is subject to several variables,
    including the internal rate of return and vesting of interests within JPM
    BHCA.</font></p>
<p align="left"><font face="serif" size="2">3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amounts shown represent the beneficial ownership of the Issuer&#8217;s equity securities by JPM BHCA, a portion of which may be deemed attributable to the Reporting Person because it is the general partner of JPMP Master Fund Manager, L.P. (&#8220;MF Manager&#8221;), the general partner of JPM BHCA.  The actual pro rata portion of such beneficial ownership that may be deemed attributable to the Reporting Person is not readily determinable because it is subject to several variables, including the internal rate of return and vesting of interests within JPM BHCA and MF Manager.</font></p>
<p align="left"><font face="serif" size="2">4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amounts shown represent the
    beneficial ownership of the Issuer's equity securities by JPM BHCA, a portion
    of which may be deemed attributable to the Reporting Person because it is
    the sole stockholder of (a) JPMP Capital Corporation, the general partner
    of MF Manager and (b) Chatham Ventures, Incorporated, the limited partner
    of JPM BHCA. The actual pro rata portion of such beneficial ownership that
    may be deemed to be attributable to the Reporting Person is not readily determinable
    because it is subject to several variables, including the internal rate of
    return and vesting of interests within JPM BHCA and MF Manager.</font></p> <p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
